Replies to post #43629 on Relief Therapeutics Holding AG (RLFTF)

[panton]

Maybe it’s because it’s design was to focus on those who’s respiratory failure progressed in spite of being on other therapies including Remdesivir and they just added to whichever therapy currently on either ZYESAMI or placebo?